Imatinib (Gleevec)

imatinib · Novartis

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Imatinib (Gleevec), covering 2009-09-15 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: 5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk [Phase 2]